8FXV image
Entry Detail
PDB ID:
8FXV
Keywords:
Title:
Crystal structure of human proTGF-beta2 in complex with Nb18
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2023-01-25
Release Date:
2023-06-21
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.24
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Transforming growth factor beta-2 proprotein
Chain IDs:A
Chain Length:393
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Nanobody clone 18
Chain IDs:B
Chain Length:124
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
A specialized integrin-binding motif enables proTGF-beta 2 activation by integrin alpha V beta 6 but not alpha V beta 8.
Proc.Natl.Acad.Sci.USA 120 e2304874120 e2304874120 (2023)
PMID: 37279271 DOI: 10.1073/pnas.2304874120

Abstact

Activation of latent transforming growth factor (TGF)-β2 is incompletely understood. Unlike TGF-β1 and β3, the TGF-β2 prodomain lacks a seven-residue RGDLXX (L/I) integrin-recognition motif and is thought not to be activated by integrins. Here, we report the surprising finding that TGF-β2 contains a related but divergent 13-residue integrin-recognition motif (YTSGDQKTIKSTR) that specializes it for activation by integrin αVβ6 but not αVβ8. Both classes of motifs compete for the same binding site in αVβ6. Multiple changes in the longer motif underlie its specificity. ProTGF-β2 structures define interesting differences from proTGF-β1 and the structural context for activation by αVβ6. Some integrin-independent activation is also seen for proTGF-β2 and even more so for proTGF-β3. Our findings have important implications for therapeutics to αVβ6 in clinical trials for fibrosis, in which inhibition of TGF-β2 activation has not been anticipated.

Legend

Protein

Chemical

Disease

Primary Citation of related structures